BioPharmX Corp company info

CIK 1504167
IRS Number 593843182
State of incorporation DE
Business address 1505 ADAMS DRIVE, SUITE D
None
MENLO PARK
CA
94025
Mail address 1505 ADAMS DRIVE, SUITE D
None
MENLO PARK
CA
94025

Short summary

BioPharmX Corp is a California company, with head office located at 1505 Adams Drive, Suite D Menlo Park, California 94025. In 2017 the company owned a total of 11.44 million USD worth of assets, including 11.28 million USD worth of current assets. The company amassed the most assets last year, totalling up to 11.44 million USD. The company net sales last year amounted to 73.00 thousand USD. The company allocated 9.14 million USD of its income to research and development.

BioPharmX Corp Income Statement

Name [in Millions USD]20102011201220132014201520162017Trends
Revenue, Net 0.060.100.07
Gross Profit -0.17-0.42-0.18
Research and development 0.030.672.525.7010.169.14
Operating Expenses 0.060.081.517.7714.9918.0116.70
Operating Income (Loss) -0.06-0.03-1.51-7.77-15.16-18.43-16.88
Interest expense 0.010.070.080.15
Other Nonoperating Income (Expense) 0.04-0.44-0.14-0.13
Income Tax Expense (Benefit) 0.000.000.00
Net income -0.06-0.09-1.59-7.81-15.60-18.41-16.64

BioPharmX Corp Balance Sheet

Name [in Millions USD]20102011201220132014201520162017Trends
Cash and cash equivalents 0.010.000.000.870.484.046.7110.93
Accounts Receivable, Net, Current 0.010.010.000.01
Inventories 0.220.080.030.01
Property, Plant and Equipment, Gross 0.000.010.060.270.300.200.24
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.000.000.010.030.090.080.13
Intangible Assets, Net (Excluding Goodwill) 0.150.140.110.10
Other Assets, Noncurrent 0.150.050.050.150.15
Total assets 0.020.000.001.651.834.817.2511.44
Current assets 0.020.000.001.261.374.436.9811.28
Non-current assets 0.150.05
Accounts payable 0.231.782.392.311.79
Total current liabilities 0.010.060.071.192.673.344.083.07
Long-term Debt 2001.65
Total liabilities 0.081.191.562.804.853.21
Common Stock, Value, Issued 0.010.010.010.010.010.030.070.19
Retained Earnings (Accumulated Deficit) -1.68-14.26-30.69-50.04-65.68

BioPharmX Corp Cash Flow

Name [in Millions USD]20102011201220132014201520162017Trends
Net income -0.06-0.09-1.59-7.81-15.60-18.41-16.64
Depreciation 0.000.000.010.030.060.140.05
Accounts receivable 0.000.01-0.000.00
Inventories 0.14-0.06-0.06-0.03
Deferred revenue 0.01
Net Cash Provided by (Used in) Operating Activities -0.01-0.05-1.08-15.75-15.59
Payments to Acquire Property, Plant, and Equipment 0.000.010.030.230.040.050.04
Payments to Acquire Intangible Assets 0.06
Net Cash Provided by (Used in) Investing Activities -0.00-0.01-0.09-0.05-0.04
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.09-0.26-0.04-0.05
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.100.080.04
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.100.080.04
Proceeds from Issuance of Common Stock 0.1013.32
Net Cash Provided by (Used in) Financing Activities 0.020.201.0318.2516.70
Cash and Cash Equivalents, Period Increase (Decrease) 0.14-0.142.112.732.461.08